SHANGHAI, China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced members of the Company's management will present at the upcoming Roth Capital China Comes to Vegas Conference, which is to be held from November 19 through November 21 at the Wynn Hotel in Las Vegas.
The conference, dedicated to U.S.-listed companies with operations in China, will bring together executives from more than 70 companies. Details of China-Biotics' presentation are:
Date: Friday, November 21, 2008
Time: 9:00 a.m. PST
Presenters: Mr. Jinan Song, Chief Executive Officer
Mr. Raymond Li, Chief Financial Officer
Mr. Henry Tai, Vice President of Corporate Development
Venue: Palmer 2
Wynn Hotel
Las Vegas
The Company will be available to meet with analysts and investors during the conference. Participation in the Roth "China Comes to Vegas" conference is by invitation only. For more information, please visit http://www.roth.com or send an e-mail to conference@roth.com.
About China-Biotics, Inc.
China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .
For more information, please contact:
CCG Investor Relations
Crocker Coulson, President
Phone: +1-646-213-1915 (New York)
Email: crocker.coulson@ccgir.com
Web: http://www.ccgirasia.com
SOURCE China-Biotics, Inc.
International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.